Sood Puneet, Gao Xiaotian, Mehta Rajil, Landsittel Douglas, Wu Christine, Nusrat Rabeeya, Puttarajappa Chethan, Tevar Amit D, Hariharan Sundaram
Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA.
Section on Biomarkers and Prediction Modeling, University of Pittsburgh Medical Center, Pittsburgh, PA.; Department of Biostatistics, University of Pittsburgh Medical Center, Pittsburgh, PA.
Transplant Direct. 2016 May 4;2(6):e75. doi: 10.1097/TXD.0000000000000586. eCollection 2016 Jun.
Improvements in renal allograft outcomes have permitted kidney transplantation after prior kidney allograft failure as well as after nonrenal solid organ transplantation. This study compares renal allograft outcomes in the 3 groups, that is, primary, repeat, and kidney after nonrenal solid organ transplantation, where transplant group was coded as a time-dependent variable.
We retrospectively reviewed registry data for kidney transplant recipients at University of Pittsburgh Medical Center from January 2000 to December 2011. We compared overall graft survival between the 3 groups using Cox regression modeling. We calculated 1-, 3-, and 5-year graft survival and half-lives for each group where feasible.
The study cohort (N = 2014) consisted of group A (primary kidney transplant, n = 1578, with 7923.2 years of follow-up time), group B (repeat kidney transplant, n = 314, with 1566.7 years of follow-up time) and group C (kidney post-nonrenal solid organ transplant, n = 176, with 844.8 years of follow-up time). Of the 1578 patients in the primary kidney transplant group, 74 later received a repeat transplant and thus also have follow-up counted in the repeat kidney transplant group. The median follow-up was 56, 53, and 55 months, respectively. The 5-year actuarial and death-censored graft survival was 68.69%, 68.79%, and 66.48% and 65.53%, 67.68%, and 62.92%, respectively (P = 0.70). There was no difference in overall graft survival in the Cox-adjusted analysis (group B: odds ratio, 1.02; 95% confidence interval, 0.84-1.26; P = 0.79; group C: odds ratio, 0.96; 95% confidence interval, 0.75-1.23; P = 0.76).
The adjusted kidney graft survivals in the 3 groups were similar.
肾移植预后的改善使得在既往肾移植失败后以及非肾实体器官移植后也可进行肾移植。本研究比较了三组肾移植的预后情况,即初次移植、再次移植以及非肾实体器官移植后的肾移植,其中移植组被编码为一个时间依赖性变量。
我们回顾性分析了2000年1月至2011年12月在匹兹堡大学医学中心接受肾移植受者的登记数据。我们使用Cox回归模型比较了三组之间的总体移植物存活率。在可行的情况下,我们计算了每组的1年、3年和5年移植物存活率及半衰期。
研究队列(N = 2014)包括A组(初次肾移植,n = 1578,随访时间7923.2年)、B组(再次肾移植,n = 314,随访时间1566.7年)和C组(非肾实体器官移植后的肾移植,n = 176,随访时间844.8年)。在初次肾移植组的1578例患者中,74例后来接受了再次移植,因此他们的随访时间也计入了再次肾移植组。中位随访时间分别为56、53和55个月。5年精算和死亡校正移植物存活率分别为68.69%、68.79%和66.48%以及65.53%、67.68%和62.92%(P = 0.70)。在Cox校正分析中,总体移植物存活率无差异(B组:比值比,1.02;95%置信区间,0.84 - 1.26;P = 0.79;C组:比值比,0.96;95%置信区间,0.75 - 1.23;P = 0.76)。
三组经校正的肾移植物存活率相似。